GlaxoSmithKline Will Open Shanghai Research Center

July 3, 2007 – GlaxoSmithKline will begin building a research facility in Shanghai that will become one of its largest research centers in the world. With an initial investment of $40 million in 2007, the company will hire between 50 and 100 first-rank international scientists at the outset. But GSK expects to continue committing funds to the center, with the goal of having 1,000 scientists at work in the facility ten years from now. Unlike other big pharma emplacements in China, the planned GSK facility will perform the entire range of drug development activities, rather than only drug discovery or clinical trials, as has been the case for other multi-national research facilities. More details...

MORE ON THIS TOPIC